These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Biocompatibility of porous polyethylene implants tissue-engineered by extracellular matrix and VEGF. Strieth S; Weger T; Bartesch C; Bittmann P; Stelter K; Berghaus A J Biomed Mater Res A; 2010 Jun; 93(4):1566-73. PubMed ID: 20014297 [TBL] [Abstract][Full Text] [Related]
46. In vivo biocompatibility and biodegradation of 3D-printed porous scaffolds based on a hydroxyl-functionalized poly(ε-caprolactone). Seyednejad H; Gawlitta D; Kuiper RV; de Bruin A; van Nostrum CF; Vermonden T; Dhert WJ; Hennink WE Biomaterials; 2012 Jun; 33(17):4309-18. PubMed ID: 22436798 [TBL] [Abstract][Full Text] [Related]
47. Evaluation of two biodegradable polymeric systems as substrates for bone tissue engineering. Mendes SC; Bezemer J; Claase MB; Grijpma DW; Bellia G; Degli-Innocenti F; Reis RL; de Groot K; van Blitterswijk CA; de Bruijn JD Tissue Eng; 2003; 9 Suppl 1():S91-101. PubMed ID: 14511473 [TBL] [Abstract][Full Text] [Related]
48. In vivo biocompatibility and vascularization of biodegradable porous polyurethane scaffolds for tissue engineering. Laschke MW; Strohe A; Scheuer C; Eglin D; Verrier S; Alini M; Pohlemann T; Menger MD Acta Biomater; 2009 Jul; 5(6):1991-2001. PubMed ID: 19286433 [TBL] [Abstract][Full Text] [Related]
49. Engineering vascularized soft tissue flaps in an animal model using human adipose-derived stem cells and VEGF+PLGA/PEG microspheres on a collagen-chitosan scaffold with a flow-through vascular pedicle. Zhang Q; Hubenak J; Iyyanki T; Alred E; Turza KC; Davis G; Chang EI; Branch-Brooks CD; Beahm EK; Butler CE Biomaterials; 2015 Dec; 73():198-213. PubMed ID: 26410787 [TBL] [Abstract][Full Text] [Related]
50. Intravital fluorescent microscopic evaluation of bacterial cellulose as scaffold for vascular grafts. Esguerra M; Fink H; Laschke MW; Jeppsson A; Delbro D; Gatenholm P; Menger MD; Risberg B J Biomed Mater Res A; 2010 Apr; 93(1):140-9. PubMed ID: 19536832 [TBL] [Abstract][Full Text] [Related]
51. Vasculogenic potential evaluation of bottom-up, PCL scaffolds guiding early angiogenesis in tissue regeneration. Rossi L; Attanasio C; Vilardi E; De Gregorio M; Netti PA J Mater Sci Mater Med; 2016 Jun; 27(6):107. PubMed ID: 27117793 [TBL] [Abstract][Full Text] [Related]
52. Vascular tissue construction on poly(ε-caprolactone) scaffolds by dynamic endothelial cell seeding: effect of pore size. Mathews A; Colombus S; Krishnan VK; Krishnan LK J Tissue Eng Regen Med; 2012 Jun; 6(6):451-61. PubMed ID: 21800434 [TBL] [Abstract][Full Text] [Related]
54. Acceleration of vascularized bone tissue-engineered constructs in a large animal model combining intrinsic and extrinsic vascularization. Weigand A; Beier JP; Hess A; Gerber T; Arkudas A; Horch RE; Boos AM Tissue Eng Part A; 2015 May; 21(9-10):1680-94. PubMed ID: 25760576 [TBL] [Abstract][Full Text] [Related]
55. Cellular Based Strategies for Microvascular Engineering. Koduru SV; Leberfinger AN; Pasic D; Forghani A; Lince S; Hayes DJ; Ozbolat IT; Ravnic DJ Stem Cell Rev Rep; 2019 Apr; 15(2):218-240. PubMed ID: 30739276 [TBL] [Abstract][Full Text] [Related]
56. Contrasting effects of vasculogenic induction upon biaxial bioreactor stimulation of mesenchymal stem cells and endothelial progenitor cells cocultures in three-dimensional scaffolds under in vitro and in vivo paradigms for vascularized bone tissue engineering. Liu Y; Teoh SH; Chong MS; Yeow CH; Kamm RD; Choolani M; Chan JK Tissue Eng Part A; 2013 Apr; 19(7-8):893-904. PubMed ID: 23102089 [TBL] [Abstract][Full Text] [Related]
57. Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization. Yu H; VandeVord PJ; Mao L; Matthew HW; Wooley PH; Yang SY Biomaterials; 2009 Feb; 30(4):508-17. PubMed ID: 18973938 [TBL] [Abstract][Full Text] [Related]
58. Acute toxicity evaluation of in situ gel-forming controlled drug delivery system based on biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer. Fang F; Gong CY; Dong PW; Fu SZ; Gu YC; Guo G; Zhao X; Wei YQ; Qian ZY Biomed Mater; 2009 Apr; 4(2):025002. PubMed ID: 19208940 [TBL] [Abstract][Full Text] [Related]
59. Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow-derived cells and a hybrid biodegradable polymer scaffold. Cho SW; Jeon O; Lim JE; Gwak SJ; Kim SS; Choi CY; Kim DI; Kim BS J Vasc Surg; 2006 Dec; 44(6):1329-40. PubMed ID: 17145438 [TBL] [Abstract][Full Text] [Related]
60. Enoxaparin does not affect network formation of adipose tissue-derived microvascular fragments. Später T; Frueh FS; Karschnia P; Menger MD; Laschke MW Wound Repair Regen; 2018 Jan; 26(1):36-45. PubMed ID: 29505164 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]